In order to assess the specificity, sensitivity, cost, and working time of five frequently used methods for detecting mutations in KRAS, we performed parallel tests using DNA extracted from 131 frozen NSCLC tissue samples. The gene discussed is KRAS; the disease is non-small cell lung carcinoma.